Literature DB >> 31594449

IRF8 induces senescence of lung cancer cells to exert its tumor suppressive function.

Jinxia Liang1, Feng Lu1, Bo Li1, Lu Liu1, Guandi Zeng1, Qian Zhou1, Liang Chen1.   

Abstract

Lung cancer is the leading cause of cancer-related deaths worldwide. However, tumor suppressor genes remain to be systemically determined for lung cancer. Here we report interferon regulatory factor 8 (IRF8), a member of the IRF family of transcription factors, as a potent lung tumor suppressor gene. Expression of IRF8 is frequently diminished in lung tumoral tissues and is associated with prognosis of non-small cell lung cancer (NSCLC) patients. Ectopic expression of IRF8 suppresses the NSCLC cells proliferation in vitro and tumorigenic potential in vivo. More importantly, forced expression of IRF8 through infection of recombinant virus inhibits lung tumorigenesis in genetically engineered mouse model (GEMM). Mechanistically, IRF8 inhibits AKT signaling and promotes accumulation of P27 protein, which results in senescence of lung cancer cells. Ectopic expression of IRF8 in tumor cells leads to regression of lung cancer tumor nodules in a xenograft tumor model. Our data, therefore, solidly shows IRF8 to be a lung cancer suppressor gene and may denote an opportunity for therapeutic intervention of NSCLC.

Entities:  

Keywords:  IRF8; NSCLC; cell cycle arrest; cell senescence; tumor suppresser gene

Year:  2019        PMID: 31594449      PMCID: PMC6927690          DOI: 10.1080/15384101.2019.1674053

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  39 in total

Review 1.  The biology and management of non-small cell lung cancer.

Authors:  Roy S Herbst; Daniel Morgensztern; Chris Boshoff
Journal:  Nature       Date:  2018-01-24       Impact factor: 49.962

2.  Induction of NF-kappaB by the Akt/PKB kinase.

Authors:  L P Kane; V S Shapiro; D Stokoe; A Weiss
Journal:  Curr Biol       Date:  1999-06-03       Impact factor: 10.834

Review 3.  PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux.

Authors:  Jake S O'Donnell; Daniela Massi; Michele W L Teng; Mario Mandala
Journal:  Semin Cancer Biol       Date:  2017-05-02       Impact factor: 15.707

4.  NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling.

Authors:  J A Romashkova; S S Makarov
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

Review 5.  Cancer stem cells in lung cancer: Evidence and controversies.

Authors:  Muhammad Alamgeer; Craig D Peacock; William Matsui; Vinod Ganju; D Neil Watkins
Journal:  Respirology       Date:  2013-07       Impact factor: 6.424

6.  Potential biomarkers involving IKK/RelA signal in early stage non-small cell lung cancer.

Authors:  Xianqing Jin; Ziming Wang; Lin Qiu; Dianliang Zhang; Zhenhua Guo; Zongwei Gao; Chun Deng; Fuling Wang; Shan Wang; Chunbao Guo
Journal:  Cancer Sci       Date:  2008-01-21       Impact factor: 6.716

7.  Principles of cancer therapy: oncogene and non-oncogene addiction.

Authors:  Ji Luo; Nicole L Solimini; Stephen J Elledge
Journal:  Cell       Date:  2009-03-06       Impact factor: 41.582

8.  IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy.

Authors:  Vinay Tergaonkar; Virginie Bottero; Masahito Ikawa; Qiutang Li; Inder M Verma
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

9.  Aberrant methylation and silencing of IRF8 expression in non-small cell lung cancer.

Authors:  Makoto Suzuki; Koei Ikeda; Kenji Shiraishi; Ayami Eguchi; Takeshi Mori; Kentaro Yoshimoto; Hidekatsu Shibata; Takaaki Ito; Yoshifumi Baba; Hideo Baba
Journal:  Oncol Lett       Date:  2014-06-11       Impact factor: 2.967

Review 10.  Epigenetic Regulation of the Epithelial to Mesenchymal Transition in Lung Cancer.

Authors:  Joëlle Roche; Robert M Gemmill; Harry A Drabkin
Journal:  Cancers (Basel)       Date:  2017-06-24       Impact factor: 6.639

View more
  5 in total

1.  Identification of prognostic candidate signatures by systematically revealing transcriptome characteristics in lung adenocarcinoma with differing tumor microenvironment immune phenotypes.

Authors:  Qiang Chen; Jiakang Ma; Xiaoyi Wang; Xiangqing Zhu
Journal:  Aging (Albany NY)       Date:  2022-06-07       Impact factor: 5.955

2.  High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancer.

Authors:  Gerardo Gatti; Courtney Betts; Darío Rocha; Maribel Nicola; Verónica Grupe; Cecilia Ditada; Nicolas G Nuñez; Emiliano Roselli; Paula Araya; Jeremías Dutto; Lucia Boffelli; Elmer Fernández; Lisa M Coussens; Mariana Maccioni
Journal:  Breast Cancer Res       Date:  2021-03-25       Impact factor: 6.466

3.  A novel pyroptosis-related gene signature to predict outcomes in laryngeal squamous cell carcinoma.

Authors:  Chongchang Zhou; Guowen Zhan; Yangli Jin; Jianneng Chen; Zhisen Shen; Yi Shen; Hongxia Deng
Journal:  Aging (Albany NY)       Date:  2021-12-15       Impact factor: 5.682

Review 4.  IRF8: Mechanism of Action and Health Implications.

Authors:  Hannah R Moorman; Yazmin Reategui; Dakota B Poschel; Kebin Liu
Journal:  Cells       Date:  2022-08-24       Impact factor: 7.666

5.  Identification of key genes in the tumor microenvironment of lung adenocarcinoma.

Authors:  Wenxing Long; Qing Li; Jianfang Zhang; Hui Xie
Journal:  Med Oncol       Date:  2021-06-12       Impact factor: 3.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.